Table 3.
Multivariate analysis across all subjects (N = 418): factors associated with major depressive episode and psychotic disorder
| Unadjusted prevalence Ratio | Prevalence Ratio | 95% CI | |
|---|---|---|---|
| Major depressive episode | |||
| Daily heroin use (in the past month) | 0.68 | 0.52 | 0.34 – 0.83 |
| Duration heroin use** | 1.16 | 1.15 | 0.97 – 1.38 |
| Current methadone treatment | 0.71 | 0.64 | 0.40 – 0.98 |
| Regular poly-substance use (ref = 0)* | |||
| One substance | 0.91 | 1.27 | 0.73 – 2.30 |
| Two substances | 0.82 | 1.23 | 0.61 – 2.47 |
| Three substances | 1.81 | 2.72 | 1.09 – 6.23 |
| Current psychotic disorder | |||
| Daily heroin use (in the past month) | 0.57 | 0.3 | 0.18 – 0.52 |
| Duration heroin use** | 1.22 | 1.17 | 0.95 – 1.47 |
| Current methadone treatment | 0.74 | 0.68 | 0.39 – 1.11 |
| Regular poly-substance use (ref = 0)* | |||
| One substance | 0.94 | 1.82 | 0.92 – 3.97 |
| Two substances | 1.15 | 2.77 | 1.21 – 6.50 |
| Three substances | 3.45 | 9.35 | 3.50 – 24.94 |
Regular poly-substance use. including daily heroin injection. regular methamphetamine use (≥ 4 times in the last 30 days). and alcohol misuse
Levels were set as follows: less than 5 years (ref); 5–10 years; 10–15 years; 15+ years. Coefficient for each level increase